Poor outcome neutropenic enterocolitis after treatment with docetaxel in a breast cancer patient

被引：0
|
作者：
Cubo, T. [1 ]
Padilla, D. [1 ]
Villarejo, P. [1 ]
Lopez, A. [1 ]
Delgado, M. [2 ]
Menendez, P. [1 ]
机构：
[1] Hosp Gen Ciudad Real, Serv Cirugia Gen & Aparato Digest, Ciudad Real, Spain
[2] Hosp Gen Ciudad Real, Serv Anat Patol, Ciudad Real, Spain
来源：
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS | 2007年 / 99卷 / 08期
关键词：
Neutropenic enterocolitis; Docetaxel; Taxotere; Cytotoxic treatment;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：480 / 482
页数：3
相关论文
共 50 条
  • [41] Patient follow-up after treatment for breast cancer
    Classe, J. -M.
    Sentilhes, L.
    Jaffre, I.
    Mezzadri, M.
    Lefebvre-Lacoeuille, C.
    Dejode, M.
    Catala, L.
    Bordes, V.
    Dravet, F.
    Descamps, P.
    JOURNAL DE GYNECOLOGIE OBSTETRIQUE ET BIOLOGIE DE LA REPRODUCTION, 2010, 39 (08): : F85 - F88
  • [42] Symptoms after breast cancer treatment: are they influenced by patient characteristics?
    Yoon, Jean
    Malin, Jennifer L.
    Tao, May Lin
    Tisnado, Diana M.
    Adams, John L.
    Timmer, Martha J.
    Ganz, Patricia A.
    Kahn, Katherine L.
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 108 (02) : 153 - 165
  • [43] Symptoms after breast cancer treatment: are they influenced by patient characteristics?
    Jean Yoon
    Jennifer L. Malin
    May Lin Tao
    Diana M. Tisnado
    John L. Adams
    Martha J. Timmer
    Patricia A. Ganz
    Katherine L. Kahn
    Breast Cancer Research and Treatment, 2008, 108 : 153 - 165
  • [44] Survivin is an independent predictor of poor outcome in breast cancer
    Hinnis, AR
    Walker, RA
    JOURNAL OF PATHOLOGY, 2006, 208 : 27A - 27A
  • [45] Survivin is a predictor of poor outcome in breast cancer.
    Hinnis, A
    Walker, RA
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S141 - S141
  • [46] Treatment of metastatic breast cancer (MBC) with Vinorelbine and Docetaxel
    Savio, Giuseppina
    Leonardi, Vita
    Alu, Massimiliano
    Laudani, Agata
    Calabria, Caterina
    Scianna, Caterina
    Agostara, Biagio
    Ascoli, Maurizio
    ANNALS OF ONCOLOGY, 2004, 15 : 48 - 48
  • [47] Docetaxel and Ifosfamide as salvage treatment in relapsed breast cancer
    Schirinzi, M. L.
    Durante, C.
    De Giorgi, D.
    Poti, O.
    Trisolini, M. P.
    De Marzi, A.
    Mancarella, S.
    ANNALS OF ONCOLOGY, 2015, 26 : 23 - 23
  • [48] Weekly docetaxel in the treatment of patients with metastatic breast cancer
    Grecea, Daniela
    Vasiliniuc, Carmen
    Ghilezan, Nicolae
    ANNALS OF ONCOLOGY, 2004, 15 : 53 - 53
  • [49] Docetaxel as adjuvant and neoadjuvant treatment for patients with breast cancer
    Heys, SD
    Sarkar, T
    Hutcheon, AW
    EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (10) : 2147 - 2157
  • [50] Docetaxel (Taxotere) in combination with anthracyclines in the treatment of breast cancer
    Nabholtz, JM
    North, S
    Smylie, M
    Mackey, J
    Au, HJ
    Au, R
    Morrish, D
    Salter, E
    Tonkin, K
    SEMINARS IN ONCOLOGY, 2000, 27 (02) : 11 - 18
12345